George Grofik | executive |
Pablo Legorreta | executive |
Christopher Hite | executive |
Marshall Urist | executive |
Terrance Coyne | executive |
Geoffrey Meacham | analyst |
Christopher Schott | analyst |
Umer Raffat | analyst |
Terence Flynn | analyst |
Chris Shibutani | analyst |
Steve Scala | analyst |
Ladies and gentlemen, thank you for standing by. Welcome to the Royalty Pharma Q4 2023 Earnings Conference Call. I would like to now turn the conference over to George Grofik, Senior Vice President, Head of Investor Relations and Communications. Please go ahead.
Thank you, and good morning and good afternoon to everyone on the call.